Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular CarcinomaKohei Shigeta, Dan G. Duda|Hepatology|2019Cited by 404
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinomaKohei Shigeta, Dan G. Duda|Journal for ImmunoTherapy of Cancer|2020Cited by 149